239 related articles for article (PubMed ID: 24816762)
1. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
Karasar P; Esendagli G
Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
[TBL] [Abstract][Full Text] [Related]
2. Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.
Dolen Y; Esendagli G
Eur J Immunol; 2013 Mar; 43(3):747-57. PubMed ID: 23175469
[TBL] [Abstract][Full Text] [Related]
3. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
5. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
[TBL] [Abstract][Full Text] [Related]
6. Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions.
Sugita S; Kawazoe Y; Imai A; Usui Y; Takahashi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6926-33. PubMed ID: 24065812
[TBL] [Abstract][Full Text] [Related]
7. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
Pittet CL; Newcombe J; Prat A; Arbour N
J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
[TBL] [Abstract][Full Text] [Related]
8. Cytosine-phosphate-guanosine-DNA induces CD274 expression in human B cells and suppresses T helper type 2 cytokine production in pollen antigen-stimulated CD4-positive cells.
Kubo S; Yamada T; Osawa Y; Ito Y; Narita N; Fujieda S
Clin Exp Immunol; 2012 Jul; 169(1):1-9. PubMed ID: 22670772
[TBL] [Abstract][Full Text] [Related]
9. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of programmed death ligands in naturally occurring postweaning multisystemic wasting syndrome.
Yue F; Cheng A; Zhu Y; Li P; Zhang Y; Sun G; Wang M; Wang X
Viral Immunol; 2015 Mar; 28(2):101-6. PubMed ID: 25594677
[TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions.
Iwamura K; Kato T; Miyahara Y; Naota H; Mineno J; Ikeda H; Shiku H
Gene Ther; 2012 Oct; 19(10):959-66. PubMed ID: 22113316
[TBL] [Abstract][Full Text] [Related]
14. Human decidual macrophages suppress IFN-γ production by T cells through costimulatory B7-H1:PD-1 signaling in early pregnancy.
Sayama S; Nagamatsu T; Schust DJ; Itaoka N; Ichikawa M; Kawana K; Yamashita T; Kozuma S; Fujii T
J Reprod Immunol; 2013 Dec; 100(2):109-17. PubMed ID: 24045115
[TBL] [Abstract][Full Text] [Related]
15. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses.
Shin T; Yoshimura K; Shin T; Crafton EB; Tsuchiya H; Housseau F; Koseki H; Schulick RD; Chen L; Pardoll DM
J Exp Med; 2005 May; 201(10):1531-41. PubMed ID: 15897272
[TBL] [Abstract][Full Text] [Related]
16. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
17. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
[TBL] [Abstract][Full Text] [Related]
18. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
[TBL] [Abstract][Full Text] [Related]
19. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
